A Science|Business Future-Proofing Medicines high-level roundtable (14:00 – 17:00 CET)
As the EU moves forward with its new pharmaceutical strategy and revising current legislation, it recognises that secure and efficient access to health data is key – both for exploiting the huge potential of new technologies and digitalisation, and for sustaining Europe’s historical excellence in health & life science sectors. In parallel, the Commission has just launched the European Health Data Space (EHDS), a robust EU-wide data infrastructure to support industry, regulators and key stakeholders in health innovation.
Against this backdrop, on June 27 the Science|Business Future-Proofing Medicines initiative will convene the first in a series of expert dialogues to explore how EU medicines legislation can anticipate and accommodate future breakthroughs in medical science, data science and digitech. This invitation-only event in Copenhagen will focus on ways in which the exchange of, and access to, health data can be improved, across sectors and borders, to support medicines development and demonstrate efficiency. Over time, by gathering best practices and thought leadership at national level, the initiative will look to develop recommendations for “future-proofing” the EU regulatory framework and accelerating the delivery of treatments to patients and citizens.